EU4Health Joint Action
Historical reference for EU4Health Joint Actions, which fund coordinated work by nominated national health authorities and associated public bodies.
EU4Health Joint Action
This page is a historical reference for the EU4Health Joint Action route. The 2025 cycle is closed. The official material does not describe this route as a standing, public grant that any three organisations can submit to whenever they choose. It describes Joint Actions as direct grants for collaboration among participating countries, with beneficiaries nominated by the competent national authorities responsible for health.
The Funding & Tenders Portal topic URL remains the reference link recorded for this page. For current programme rules, applicants should also read the European Health and Digital Executive Agency (HaDEA) guidance on how to apply and the HaDEA calls and contracts page. Those pages explain the difference between open calls, procurement, direct grants, and Joint Actions.
Current status
The 2025 Joint Action cycle has ended. The 2025 EU4Health Work Programme was published by the European Commission on 23 July 2025. It included several targeted direct-grant actions that were expected to be implemented by HaDEA and delivered by Member States’ authorities. The relevant nomination process was not an ordinary open call with a universal application deadline. Participating countries nominated one or more competent authorities, and the Commission’s transmission date for Joint Action nominations was 16 October 2025. A country could set an earlier national deadline so that its ministry or health board had time to assess candidates and send a complete nomination.
There is no confirmed new deadline for this page. HaDEA’s current tentative calendar says that the 2026 call-planning section will be updated after the 2026 Annual Work Programme is published. That is not an announcement of a new Joint Action, a new topic identifier, or an opening date. Do not use the date in the front matter as a live submission opportunity. It records the closed 2025 cycle so that the page remains a useful archive entry.
The programme itself continues during the 2021–2027 period, but that does not mean this particular topic is continuously open or that the same topic will return unchanged. A future Annual Work Programme may contain related actions with a different scope, budget, eligibility rule, identifier, and timetable. Treat every future topic as a fresh decision.
What a Joint Action is
HaDEA defines Joint Actions as collaborative projects involving several EU and associated countries. The purpose is to share, test, refine, and implement tools, methods, or approaches for a health issue that has value beyond one national system. The work is carried out through a consortium of national public health authorities nominated by participating countries.
That structure makes this route different from an open action grant. An open action grant may invite eligible legal entities to submit proposals directly through the Funding & Tenders Portal. A Joint Action begins with a policy topic in an Annual Work Programme and a national nomination process. The nominated authorities then work with the Commission and HaDEA on the proposal, consortium structure, work packages, budget, and grant agreement.
The practical audience is therefore narrower than the old page suggested. A university, research institute, hospital, NGO, or private organisation may have a useful role, but it cannot assume that it can become a direct beneficiary simply by forming a three-country consortium. Its route into a Joint Action normally depends on a competent authority, a permitted affiliated-entity relationship, a subcontract, or a collaborating-stakeholder role under the specific action.
What the 2025 cycle covered
The 2025 work programme organised EU4Health activity across crisis preparedness; health promotion and disease prevention; cancer, cardiovascular disease, and other non-communicable diseases; health systems and the healthcare workforce; digital health; and other programme activities. The Joint Action topics were distributed across those policy areas rather than collected into one grant with one universal project description.
Examples in the 2025 work programme included direct grants for HERA training and exercise activity, a coordinated One Health surveillance system for cross-border pathogens, actions concerning health data access bodies, implementation of medicines and medical-device rules, clinical-trials cooperation, and work to maximise the impact of the EU Global Health Strategy. Each topic had its own objective and target authorities. A health organisation should not copy the scope of one example into another topic.
The 2025 work programme also makes clear that the programme has a topic-level budget structure. It lists, among other examples, EUR 2,947,923 for the HERA training and exercise direct grant, EUR 15,000,000 for the One Health surveillance direct grant, EUR 4,000,000 for a medical-device Joint Action, EUR 4,700,000 for a clinical-trials Joint Action, and EUR 2,500,000 for the EU Global Health Strategy Joint Action. These figures are indicative EU contributions for named actions, not a general award ceiling for every Joint Action. The correct amount for a future page must come from that future topic’s work programme or call documents.
EU4Health grants normally involve co-financing. The 2025 work programme states a maximum Union co-financing rate of 60% of eligible action costs, with a possible increase to 80% for exceptional utility when the applicable conditions are met. A specific topic or grant agreement may apply more detailed rules. The EU contribution is not unrestricted income, and the consortium must be able to support the required share of eligible costs and document expenditure.
Eligibility
The first eligibility question is not “Do we have three partners?” It is “Can the organisation be nominated or properly included for this exact topic?” HaDEA’s guidance identifies Joint Actions and other direct grants as funding for competent health authorities nominated by EU and eligible non-EU countries. The 2025 nomination material further explains that each participating country may nominate one or more competent authorities, which become direct beneficiaries and share responsibility for implementation.
A credible competent authority will normally have all of the following:
- a public-health mandate that matches the topic;
- legal establishment in an EU Member State or a country associated with EU4Health, unless the topic states another eligible arrangement;
- authority to represent the country in the relevant health policy area;
- sufficient professional, administrative, and financial capacity to perform the action;
- the ability to contribute co-financing and maintain auditable records; and
- staff who can work with the other national authorities, the coordinator, HaDEA, and the Commission.
An affiliated entity is not simply any friendly partner. The official nomination guidance describes a structural relationship with the beneficiary, such as a legal, capital, or qualifying standing cooperation link that is not created only for the project. Public-sector bodies such as national institutes, public-health schools, and research centres may qualify when they are publicly funded or controlled to deliver a public or governmental service. The exact topic rules still control.
Subcontractors and collaborating stakeholders have different roles. A subcontractor may be hired for a defined service that the beneficiaries cannot provide internally and must be selected under applicable procurement rules. A collaborating stakeholder may contribute expertise or participation without receiving a direct EU grant. Neither role should be described as a direct beneficiary unless the topic documents expressly allow it.
NGOs, universities, hospitals, and private organisations should check the specific topic before investing in a proposal. The general EU4Health programme supports a wide range of legal entities through different instruments, but the Joint Action route is narrower. A non-profit label alone does not create eligibility, and a commercial organisation should not assume that it can lead a national authority consortium.
How the 2025 application route worked
The following sequence describes the closed cycle and is useful for preparing for a future one. It is not a live application instruction.
Find the exact topic. Read the Annual Work Programme entry and identify the topic code, policy objective, expected results, indicative budget, implementation method, and intended applicants. Do not rely on the generic phrase “EU4Health Joint Action.”
Contact the responsible national channel. A potential participant should approach the ministry of health, national health board, or designated EU4Health focal point in the relevant country. The national authority manages its own transparent nomination procedure and may limit the number of candidates.
Choose the role. State whether the organisation seeks nomination as a Competent Authority or inclusion as an Affiliated Entity. If the organisation is not eligible for either role, it may still communicate interest in a subcontractor or collaborating-stakeholder role, but it should not describe that interest as an application for the grant.
Prepare evidence. The 2025 national instructions required a signed request and a detailed organisational curriculum describing relevant professional, scientific, and European or international project experience. A candidate also needed to identify the requested participation type and provide material that allowed the ministry to assess its authority, technical fit, and administrative capacity.
Complete the nomination process. The 2025 Joint Action nominations used an EU Survey process with a completed and signed nomination form. The responsible national authority submitted the nomination in line with the Commission’s instructions. A future cycle may use a different form or portal, so old access details should not be reused.
Build the proposal after nomination. The preparation phase starts with the nominated competent authorities. They agree the coordinator, work-package leaders, outputs, milestones, partner responsibilities, budget, reporting arrangements, and quality controls. Affiliated entities can be included where the structural relationship and topic rules support that role.
Complete grant preparation and delivery planning. Before signature, every beneficiary should confirm its legal status, mandate, internal approvals, co-financing, procurement plan, data-protection responsibilities, and record-keeping process. After signature, implementation is managed against the grant agreement, not against the broad programme description.
Materials to prepare for a future cycle
A useful preparation file should contain the exact topic text; a one-page statement of the organisation’s public-health mandate; evidence of legal status and the structural relationship to any proposed beneficiary; a record of relevant projects; named technical and financial leads; a country-level nomination plan; and a short explanation of the outputs the organisation can deliver.
For the consortium itself, prepare a responsibility matrix that identifies the coordinator, each competent authority, each affiliated entity, work-package leads, deliverable owners, data owners, procurement responsibilities, and approval points. Include a risk register for nomination delays, partner withdrawal, data access, language and translation needs, staff availability, and co-financing. This is more useful than a broad partnership list with no assigned work.
For the budget, connect every major cost to an output and an accountable beneficiary. Separate coordination, technical work, travel, meetings, translation, external services, equipment, and reporting. Confirm whether a proposed external service is a subcontract or a beneficiary task. Keep records that can show why the cost is necessary, eligible, and reasonable under the grant agreement.
What to do now
There is no action to submit against the closed 2025 date. An organisation seeking immediate EU4Health funding should use HaDEA’s current calls-for-proposals pages and Funding & Tenders Portal topic search for an open action grant or tender that matches its legal status. It should not treat the historical Joint Action page as an open invitation.
An organisation preparing for a future Joint Action should monitor the next Annual Work Programme, maintain contact with its national health authority or EU4Health focal point, and keep its organisational evidence current. Once a future topic is published, compare its scope and eligibility line by line with the archived 2025 material. Confirm the national nomination deadline, the Commission transmission date, the permitted roles, the co-financing rate, and the required forms before writing a proposal.
The key lesson from this page is simple: EU4Health Joint Actions are country-led, topic-specific direct grants. They can support substantial cross-border public-health work, but they are not rolling grants, not a generic three-partner competition, and not a promise of EUR 8 million for any eligible consortium. The closed date is retained here for historical accuracy; readers must use a newly published official topic for any future application.